Marijuana Rescheduling Tracker: Where Schedule III Stands

Checked November 14, 2026

Marijuana is only partly rescheduled. Since April 28, 2026, FDA-approved marijuana products and marijuana handled under a state medical marijuana license are in Schedule III. All other marijuana, including adult-use, stays in Schedule I while a DEA hearing on the broader 2024 proposal waits for the judge's recommended decision.

Where rescheduling stands (checked November 14, 2026)

  • State-licensed medical marijuana: Schedule III since April 28, 2026, under 91 FR 22714 (AG Order No. 6754-2026).
  • FDA-approved marijuana products: Schedule III under the same order. Synthetic THC and hemp are outside it.
  • Adult-use and all other marijuana: Schedule I. The order leaves it there; the broader move proposed in 89 FR 44597 is still before DEA.

Next step: a recommended decision from Chief Administrative Law Judge Derek C. Julius in Hearing Docket No. 26-96. Briefing on the GAO report closed with reply briefs due November 5, 2026. As of November 14, neither DEA's hearing documents page nor DEA's rescheduling page lists a recommended decision. Any change for adult-use marijuana would come in a final rule published in the Federal Register.

Petitions for review of the April order are pending in the U.S. Court of Appeals for the D.C. Circuit, including No. 26-1130, filed by Nebraska, Indiana and Louisiana. The order stays in effect while they are pending.

Rescheduling timeline, every filing and order

Newest at the bottom. Each row links to the document it rests on.

DateWhat happenedDocumentCoverage
Oct. 6, 2022The President asks the Attorney General and HHS to review how marijuana is scheduled.89 FR 44597 (background)
Aug. 29, 2023HHS recommends Schedule III to DEA.89 FR 44597 (background)
May 21, 2024DEA proposes moving marijuana from Schedule I to Schedule III (Docket No. DEA-1362).89 FR 44597Our coverage
Aug. 29, 2024First notice of hearing; hearing set for Dec. 2, 2024.Recited at 91 FR 22778
Jan. 13, 2025The presiding judge stays the 2024 hearing pending an interlocutory appeal.Recited at 91 FR 22778
Dec. 18, 2025Executive Order 14370, Increasing Medical Marijuana and Cannabidiol Research, directs the Attorney General to finish the Schedule III rulemaking. Published Dec. 23, 2025 at 90 FR 60541.Cited at 91 FR 22777Our coverage
Apr. 28, 2026Final order in effect: FDA-approved marijuana products and state-licensed medical marijuana move to Schedule III. Signed Apr. 22.91 FR 22714Our coverage
Apr. 28, 2026The 2024 hearing is withdrawn and a new hearing is noticed on the broader proposal.91 FR 22778; 91 FR 22777Our coverage
May 22, 2026Nebraska, Indiana and Louisiana petition the D.C. Circuit to review the April order.No. 26-1130Our coverage
June 2026The judge grants Louisiana's motion to withdraw from the hearing.DEA hearing documents
June 29, 2026The hearing opens in Arlington, Virginia (Hearing Docket No. 26-96).DEA release, June 25, 2026Our coverage
July 15, 2026The hearing closes.ALJ order, Sept. 29, 2026Our coverage
July 2026The judge orders transcript corrections and post-hearing briefs.DEA hearing documentsOur coverage
Sept. 23, 2026GAO publishes GAO-26-108623 on DEA and HHS drug scheduling.GAO-26-108623
Sept. 29, 2026The judge stays the case while a motion to admit the GAO report is briefed.Stay and briefing order
Oct. 22, 2026The judge admits the GAO report, allows supplemental briefs and denies a motion to reopen the hearing.ALJ order, Oct. 22, 2026Our coverage
Nov. 5, 2026Reply briefs due; the stay ends by the order's terms.ALJ order, Oct. 22, 2026
Nov. 14, 2026No recommended decision listed on DEA's pages.DEA hearing documents

What Schedule III changes, and what it does not

  • Scope. Only FDA-approved marijuana products and marijuana under a state medical license moved. Adult-use marijuana, synthetic THC and hemp did not.
  • DEA registration and interstate sales. A Schedule III substance is still a controlled substance that only DEA registrants may handle, so the move did not make interstate sales lawful. The order let medical licensees who applied for registration within 60 days of publication keep operating under their state license while DEA reviews. See our registration coverage.
  • Section 280E. The tax code at 26 U.S.C. 280E denies deductions to businesses trafficking in Schedule I or II substances. State-licensed medical marijuana is now in Schedule III; adult-use marijuana is still in Schedule I. Treasury and the IRS described their process for tax guidance on April 23, 2026. This is not tax advice; see the 280E playbook and talk to your tax adviser.
  • Banking. The order does not mention banks, and FinCEN has not replaced its 2014 guidance. See the cannabis banking guide.
  • Research. Executive Order 14370, titled Increasing Medical Marijuana and Cannabidiol Research, directed the Attorney General to finish the Schedule III rulemaking.
  • State law. Federal scheduling does not change state licensing, possession limits or penalties. Check state cannabis and hemp laws.
  • Workplace drug testing. Employer policy questions under the two-tier system are covered in rescheduling and workplace rules.

Frequently asked questions

Is marijuana rescheduled yet?

Partly. Since April 28, 2026, FDA-approved marijuana products and marijuana under a state medical marijuana license are in Schedule III. Adult-use marijuana is still in Schedule I.

Moving marijuana from Schedule I, the most restricted category of the Controlled Substances Act, to Schedule III. A Schedule III substance is still controlled: it can be handled only by DEA registrants, and Section 280E, which reaches only Schedule I and II substances, no longer covers it.

Chief Administrative Law Judge Derek C. Julius issues a recommended decision on the broader 2024 proposal. As of November 14, 2026, none is listed on DEA's pages. Any change for adult-use marijuana would come in a final rule published in the Federal Register.

Yes. The April 2026 order leaves adult-use marijuana in Schedule I. State adult-use programs keep operating under state law.

No. The order excludes hemp. Hemp has its own federal change on December 11, 2026, when the total-THC test and the 0.4 mg per container cap take effect.

Sources

The Regulator Brief
Every cannabis and hemp rule that moved this week, in one Monday email.
4 minutes. Mondays at 6 AM ET. Primary-source links on every claim.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Regulatory journalism, not legal advice. CannabisRegulations.ai reports what the law says on the date checked; it does not advise on any business or product. Laws and enforcement change often. For a decision about your products, talk to a licensed attorney in your state. Our lawyer directory lists attorneys; listings are not endorsements.

Checked November 14, 2026 against the Federal Register, DEA and court documents cited above.

This is regulatory journalism, not legal advice. Talk to your counsel.